These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo. Riuzzi F; Sorci G; Donato R J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300 [TBL] [Abstract][Full Text] [Related]
4. Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system. Sotokawauchi A; Matsui T; Higashimoto Y; Yamagishi SI Diab Vasc Dis Res; 2019 Nov; 16(6):556-561. PubMed ID: 31375034 [TBL] [Abstract][Full Text] [Related]
5. AGEs, RAGEs and s-RAGE; friend or foe for cancer. Ahmad S; Khan H; Siddiqui Z; Khan MY; Rehman S; Shahab U; Godovikova T; Silnikov V; Moinuddin Semin Cancer Biol; 2018 Apr; 49():44-55. PubMed ID: 28712719 [TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end-products induce skeletal muscle atrophy and dysfunction in diabetic mice via a RAGE-mediated, AMPK-down-regulated, Akt pathway. Chiu CY; Yang RS; Sheu ML; Chan DC; Yang TH; Tsai KS; Chiang CK; Liu SH J Pathol; 2016 Feb; 238(3):470-82. PubMed ID: 26586640 [TBL] [Abstract][Full Text] [Related]
7. Assay for advanced glycation end products generating intracellular oxidative stress through binding to its receptor. Kobori T; Ganesh D; Kumano-Kuramochi M; Torigoe K; Machida S Anal Biochem; 2020 Dec; 611():114018. PubMed ID: 33186591 [TBL] [Abstract][Full Text] [Related]
8. Allicin Alleviates Diabetes Mellitus by Inhibiting the Formation of Advanced Glycation End Products. Li L; Song Q; Zhang X; Yan Y; Wang X Molecules; 2022 Dec; 27(24):. PubMed ID: 36557926 [TBL] [Abstract][Full Text] [Related]
9. The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway. Ren L; Lou Y; Sun M Bioengineered; 2021 Dec; 12(1):5985-5995. PubMed ID: 34477479 [TBL] [Abstract][Full Text] [Related]
10. Insulin-Like Growth Factor-I Protects Against the Detrimental Effects of Advanced Glycation End Products and High Glucose in Myoblastic C2C12 Cells. Adachi N; Kanazawa I; Tanaka KI; Takeno A; Notsu M; Tanaka S; Sugimoto T Calcif Tissue Int; 2019 Jul; 105(1):89-96. PubMed ID: 30809689 [TBL] [Abstract][Full Text] [Related]
11. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions. Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227 [TBL] [Abstract][Full Text] [Related]
12. Cathepsin D Attenuates the Proliferation of Vascular Smooth Muscle Cells Induced by the AGE/RAGE Pathway by Suppressing the ERK Signal. Ye N; Miao L; Wang F; Wu S; Wu B; Zhou Y; Wang C; Sun G Curr Pharm Des; 2023; 29(30):2387-2395. PubMed ID: 37855363 [TBL] [Abstract][Full Text] [Related]
13. Fructose-induced AGEs-RAGE signaling in skeletal muscle contributes to impairment of glucose homeostasis. Rai AK; Jaiswal N; Maurya CK; Sharma A; Ahmad I; Ahmad S; Gupta AP; Gayen JR; Tamrakar AK J Nutr Biochem; 2019 Sep; 71():35-44. PubMed ID: 31272030 [TBL] [Abstract][Full Text] [Related]
14. Androgens Increase Accumulation of Advanced Glycation End Products in Granulosa Cells by Activating ER Stress in PCOS. Azhary JMK; Harada M; Kunitomi C; Kusamoto A; Takahashi N; Nose E; Oi N; Wada-Hiraike O; Urata Y; Hirata T; Hirota Y; Koga K; Fujii T; Osuga Y Endocrinology; 2020 Feb; 161(2):. PubMed ID: 32020188 [TBL] [Abstract][Full Text] [Related]
15. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions. Neviere R; Yu Y; Wang L; Tessier F; Boulanger E Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623 [TBL] [Abstract][Full Text] [Related]
16. The receptor for advanced glycation end-products enhances lung epithelial wound repair: An in vitro study. Zhai R; Blondonnet R; Ebrahimi E; Belville C; Audard J; Gross C; Choltus H; Henrioux F; Constantin JM; Pereira B; Blanchon L; Sapin V; Jabaudon M Exp Cell Res; 2020 Jun; 391(2):112030. PubMed ID: 32330509 [TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes. Sun Y; Kang L; Li J; Liu H; Wang Y; Wang C; Zou Y J Cell Mol Med; 2016 Oct; 20(10):1945-55. PubMed ID: 27297874 [TBL] [Abstract][Full Text] [Related]
18. Advanced Glycation End Products Affect Osteoblast Proliferation and Function by Modulating Autophagy Via the Receptor of Advanced Glycation End Products/Raf Protein/Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase/Extracellular Signal-regulated Kinase (RAGE/Raf/MEK/ERK) Pathway. Meng HZ; Zhang WL; Liu F; Yang MW J Biol Chem; 2015 Nov; 290(47):28189-28199. PubMed ID: 26472922 [TBL] [Abstract][Full Text] [Related]
19. Accumulation of Advanced Glycation End Products Involved in Inflammation and Contributing to Severe Preeclampsia, in Maternal Blood, Umbilical Blood and Placental Tissues. Chen W; Zhang Y; Yue C; Ye Y; Chen P; Peng W; Wang Y Gynecol Obstet Invest; 2017; 82(4):388-397. PubMed ID: 27505171 [TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products decrease collagen I levels in fibroblasts from the vaginal wall of patients with POP via the RAGE, MAPK and NF-κB pathways. Chen YS; Wang XJ; Feng W; Hua KQ Int J Mol Med; 2017 Oct; 40(4):987-998. PubMed ID: 28849117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]